SCHEMBL5067217

SCHEMBL5067217

O=C(O)n1c(CO)cc2ccc(F)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 1/20 0.39
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
PLA2G10 O15496 1/20 0.36
NTRK1 P04629 1/20 0.36
FABP4 P15090 1/20 0.33
CBX7 O95931 1/20 0.32
CDYL Q9Y232 1/20 0.32
HTR2C P28335 2/20 0.32
HTR2A P28223 1/20 0.32
DAO P14920 1/20 0.32
PDPK1 O15530 1/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
APEX1 P27695 1/20 0.32
CYP2C19 P33261 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25253592 0.81 KMO (0.41) KDM4EALDH1A1HSD17B10PLA2G10FABP4
SCHEMBL16835376 0.80 ALDH1A1 (0.37) CCR2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL5058104 0.79 NR1H2 (0.41)
SCHEMBL16835425 0.78 OXER1 (0.46) CCR2ALDH1A1DAOTSHR
SCHEMBL25184142 0.77 MTNR1A (0.49) CCR2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL35212138 0.75 KDM4E (0.39) KDM4EALDH1A1HPGDHSD17B10HTR2C
SCHEMBL5063155 0.74 DAO (0.32) DAO
SCHEMBL4048040 0.73 KDM4E (0.45) CCR2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL5065652 0.71 SMN1; SMN2 (0.43) KDM4EALDH1A1HTR2ALMNA
SCHEMBL21684662 0.67 NR1H2 (0.45) KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255111-A1 Tissue Factor Production Inhibitor SANKYO COMPANY LIMITED (JP) 2008-10-16 US disclosed
CN-101119747-A Tissue factor production inhibitor SANKYO CO (JP) 2008-02-06 CN disclosed
EP-1764075-A1 TISSUE FACTOR PRODUCTION INHIBITOR Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255111-A1 Tissue Factor Production Inhibitor PTAFR, PLAT, TFPI CCR2 1925/4885KDM4E 4805/4885ALDH1A1 4330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.